Blog - My blog
15339
paged,page-template,page-template-blog-masonry,page-template-blog-masonry-php,page,page-id-15339,paged-2,page-paged-2,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Blog

Even during the COVID-19 pandemic, opioid misuse has continued unabated in the United States, with an estimated 2.5 million or more Americans suffering from opioid use disorder. Most people treated for the disorder are given medications, such as buprenorphine, that activate opioid receptors. But there...

Benzodiazepines (a class of sedative medications best known by brand names like Valium, Xanax, and Klonopin) may be prescribed to patients who are receiving buprenorphine treatment for opioid use disorder (an opioid agonist medication best known in formulation with naloxone, marketed as Suboxone). Clinicians accept that there are both risks,...

Abstract Background and aims Evidence from randomized controlled trials establishes that medication treatment with methadone and buprenorphine reduces opioid use and improves treatment retention. However, little is known about the role of such medications compared with non‐medication treatments in mitigating overdose risk among US patient populations receiving...

Physicians who treat opioid addiction also have the option of utilizing ‘medication-assisted treatment,’ and the most common medications used in the treatment of opioid dependence today are methadone, naltrexone, and buprenorphine (Suboxone). Most people cannot just walk away from opioid addiction. They need help to change their thinking,...

1. Introduction Opioid use is epidemic in the US, with overdose deaths increasing nearly 28% from 2015 to 2016, and emergency medicine systems across the country facing a growing burden of overdoses (Vivolo-Kantor et al., 2018). Expanding access to evidence-based medications for opioid use disorder (MOUDs) is a central tool...